Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Novo Nordisk will sell its blockbuster weight-loss drug Wegovy for under half its normal price via a new direct-to-consumer online pharmacy.
Policies floated by European Union leaders that could boost the bloc’s defense spending have sent the company’s shares flying.
The titanic port deal immediately made political waves, even as the seller, conglomerate CK Hutchison, denied politics were at play.
Netflix is rolling out the first major redesign of its home hub since 2013, hoping people might watch more if inundated with less.
Here’s the bad news: Auto manufacturing is a notoriously thin-margin industry, and tariffs could tear right through those margins.
The biggest restaurant chain in the world just completed a splashy IPO — and you’ve likely never heard of it.
Eli Lilly last week announced a $27 billion investment in four different domestic manufacturing plants to boost weight-loss drug production.
DoorDash binged Wednesday on British delivery rival Deliveroo, which it is set to acquire in a $3.9 billion deal.
On Wednesday, Bloomberg reported that one billion people are watching podcasts on the Google-owned YouTube every month.
European leaders are gearing up for the possibility of a sudden America-shaped hole in the Ukraine defense budget.
Now that semaglutide’s no longer in shortage territory, the FDA said drug-makers have 90 days to wrap up production of their Novo knockoffs.
Microsoft hasn’t signed off on OpenAI’s dramatic reversal of its onetime plan to become a for-profit venture.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
As the US — and everywhere else — has digested multi-year inflation, pressure has mounted disproportionately on the restaurant sector.